ERAS Earnings & Financial Statements
Erasca, Inc.
$15.35
+$1.23(+8.68%)
42
Overall
40
Value
54
Tech
34
Quality
Market Cap
$4.94B
Volume
5.16M
52W Range
$2.11 - $24.28
Target Price
$23.70
ERAS earnings and financial statements: Erasca, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ERAS Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | $1.29M | - | - | - |
| Operating income | -$140.91M | -$179.59M | -$141.53M | -$247.45M | -$124.88M |
| EBITDA | -$138.05M | -$177.94M | -$121.31M | -$142.81M | -$86.83M |
| Net income | -$124.55M | -$161.65M | -$125.04M | -$242.81M | -$122.76M |
| EPS (diluted) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $396.15M | $502.53M | $395.30M | $514.91M | $501.42M |
| Total liabilities | $70.98M | $79.03M | $78.61M | $103.06M | $44.89M |
| Shareholders’ equity | $325.17M | $423.50M | $316.69M | $411.85M | $456.53M |
| Cash and equivalents | $73.81M | $67.74M | $93.08M | $284.22M | $360.49M |
| Long-term debt | $42.07M | $47.27M | $51.89M | $53.79M | $18.51M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$95.45M | -$109.42M | -$101.22M | -$103.26M | -$79.60M |
| Capital expenditure | -$128.0K | -$60.0K | -$21.77M | -$16.55M | -$18.89M |
| Free cash flow | -$95.58M | -$109.48M | -$122.99M | -$119.81M | -$98.48M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ERAS | $15.35 | +8.7% | 5.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |